Background
Farmers in industrialized countries have low morbidity in general and common disease entities as cancer and cardiovascular disorders are less frequent among farmers than in the general population [
1]. By contrast, farmers have an increased risk of acquiring musculoskeletal disorders (MSD), such as osteoarthritis of the hip, low back pain, and neck and upper limb complaints [
1‐
3]. The reason for this is not known. We have previously demonstrated that the increased risk cannot be fully explained by known risk factors such as physical work load, psychosocial factors, or life style, indicating that other etiological factors must be involved. [
2‐
4]. Interestingly, the prevalence of low back pain in farmers is associated not only with other musculoskeletal symptoms but also with chest discomfort, dyspepsia, symptoms from eyes, nose and throat mucous membranes, skin problems, work-related fever attacks, and primary care appointments due to digestive disorders [
4]. This comorbidity points to the possibility that MSD in farmers may be part of a more systemic disorder with pathological changes in many organs and tissues. Since blood is in direct contact with all tissues, such changes are likely to be reflected in plasma [
5] and quantitative changes in the plasma could thus serve as biomarkers of systemic effects. Moreover, plasma samples are readily available for investigation, thus making analysis of plasma a favorable alternative for examining laboratory signs of a systemic disorder. In a recent study serum samples from patient with discogenic chronic low back pain (DLBP) were analyzed by mass spectrometry to identify biomarkers for DLBP [
6].
In this study, our objective was to identify plasma proteins that might differentiate farmers with MSD from matched rural referents. We focused on relatively abundant plasma proteins which can be quantified to the nanogram range using two-dimensional gel electrophoresis (2DE) with silver staining and subsequent identification by mass spectrometry (MS).
Discussion
Using 2-DE and mass spectrometry proteomic techniques, we were able to identify 15 proteins that were present differently in the plasma of farmers with MSD and their matched rural referents. Several of the proteins with plasma levels higher among farmers than among referents are well known as mediators or indicators of inflammation. For example
, complement factor B is essential for complement activation via the alternate pathway and so plays an important role in inflammatory conditions such as arthritis [
14‐
16] and muscle inflammation [
17].
Haptoglobin is established as an inflammation-inducible plasma protein [
18] that exerts a regulatory activity on immune cell responses and host immunity [
19]. Accordingly, haptoglobin was found to be a monocyte chemoattractant whose chemotactic potential was mediated, at least in part, by its interaction with chemokine (C-C motif) receptor 2 [
20]. Recently, Park and co-workers demonstrated that the C-terminal haptoglobin fragment is generated by plasmin in local inflammatory environments, suggesting that this fragment might be applied as a novel biomarker for the diagnosis and prognosis of inflammatory joint diseases such as rheumatoid arthritis [
21].
Hemopexin belongs to the acute phase reactants, the synthesis of which is induced after inflammation. Aside from a systemic role in preventing heme-mediated oxidative stress, hemopexin might act as a local antioxidant at sites of injury and so play a role in inflammation [
22].
Analogously, some of the proteins with plasma levels lower among the farmers than among the referents (Table
3) are known to have anti-inflammatory properties and actions. Thus,
antitrombin III has been shown to inhibit cytokine and tissue factor production in endothelial cells [
23], attenuate CD11b/CD18 expression in activated neutrophils and monocytes [
24], suppress granule secretion in activated platelets [
25], prevent apoptosis of hepatocytes [
26,
27], and improve endotoxin-induced acute lung injury in rats [
28].
Alpha-2-HS-glycoprotein a multifunctional molecule that may serve as an inhibitor of systemic inflammation in mice [
29] and humans [
30,
31]; notably, its serum levels were significantly decreased in patients with RA [
32,
33]. V
itamin D-binding protein (VDBP) is primarily known as a transport protein but was found to be down-regulated in serum of experimental animals with systemic inflammation [
34] and patients with sepsis [
35,
36]. Moreover, Oh and coworkers recently found this protein to be down-regulated in serum of patients with carpal tunnel syndrome [
37], a condition causing pain, impairment, and disability. The molecular mechanisms connecting inflammation with decreased VDBP are not clear, but because VDBP is a precursor for macrophage activating factor (MAF) it may be speculated that the decreased levels reflect increased formation of MAF and ensuing activation of macrophages [
38] and neutrophils [
39] at sites of inflammation. Alternatively, MAF may function positively by causing death of the macrophages when activated macrophages are no longer needed at the site of inflammation [
40] Clearly, much further investigation is needed to elucidate why farmers with MSD appear to have decreased serum levels of VDBP.
One of the most important aspects of using 2DE is the capability of resolving many post-translationally modified proteins that may appear as isoforms. We identified two isoforms of hemopexin that both were present in higher amounts in the plasma of farmers (Table
3, Fig.
4). Moreover, we identified two proteins (kininogen and alpha-1-antitrypsin) that were present differently in the plasma of farmers and referents depending on isoform, i.e., one isoform was present in a higher amount in the farmer group
vs the referent group, and another isoform was present in a higher amount in the referent group
vs the farmer group (Table
3, Fig.
4). While we are unable to conclusively explain these findings, it can be noted that these proteins, too, are being associated with inflammatory processes and diseases. Thus,
kininogen is the precursor of bradykinin, a well-known mediator of inflammation and pain [
41‐
43] that plays a crucial role in rheumatoid arthritis [
44].
Alpha-1-antitrypsin can exert anti-inflammatory activity in many tissues and organs including the musculoskeletal system; notably, low levels of alpha-1-antitrypsin have been suggested to contribute to the development of rheumatoid arthritis [
45] and MSD [
46]. Yet, changes in isoforms of kininogen, alpha-1-antitrypsin, and hemopexin have not previously been reported. We do not know the exact chemical nature of the isoforms found in our study and are currently attempting to ascertain post-translational modifications. Characterization of the chemical nature of these protein isoforms, determination of the tissue(s) that produce them, and the relationship between these isoforms and other interacting proteins—all of these, as they relate to the causal events of MSD, may lead to a further understanding of the progression to MSD in farmers.
While the levels of leucine-rich alpha-2- glycoprotein were higher in the farmer group, the levels of alpha-1B-glycoprotein were higher in the referent group (Table
3). Whether these proteins, too, are involved in inflammation or not remains unclear. The physiological role of
leucine-rich alpha-2- glycoprotein is not known; however, its 33 % sequence homology with a beta-type phospholipase A2 inhibitor [
47] suggests the possibility that it might modulate inflammation and pain through inhibition of phospholipase A2 activity. As to
alpha-1B-glycoprotein, decreased plasma levels of this protein were found in patients with rheumatoid arthritis [
32] but little is known about the function of this protein and the biological relevance of this finding is therefore uncertain. The reason why
serotransferrin (the major iron-transporting plasma protein) was higher in the farmer group is also uncertain; interestingly, its plasma levels were affected in an experimental model of neuropathic pain [
48].
Apolipoprotein A1 (ApoA1) has been shown to have anti-inflammatory properties and to reduce atherosclerosis [
49]; one would expect, therefore, that farmers (who are at lower risk for cardiovascular disease than the general population) had higher (rather than lower) apoA1 than referents. On the other hand, the level of apoA1 in lipoproteins has been found to correlate positively with PCYOX1 [
50], an enzyme which generates H
2O
2 and so probably plays a role in atherogenesis [
51]
. Based on this finding, Sun and coworkers suggested that high apoA1 content might be associated with increased risk of cardiovascular disease [
50]. Further investigation is required to clarify the reason why farmers with MSD appear to have decreased serum levels of apo A1.
Although we were able to identify a protein profile that differentiates farmers with MSD from referents using proteomic techniques, the methods used in this study may pose some limitations. We used isoelectric points and molecular weight of the proteins to separate the proteins onto a two-dimensional gel. We were limited therefore to investigating proteins within a certain range of isoelectric points and molecular weight, thereby excluding several proteins that may be potential candidates for biomarkers of MSD in farmers. Furthermore, we used a depletion column to remove the high abundant proteins (albumin and IgG) before analysis these proteins give substantial background to the 2DE profiles and make analysis difficult [
5]; it is not impossible that this procedure might have eliminated some other candidates. As to the protein resolution, we have little reason to believe that the methods used have posed further limitations; rather, an advantage of 2DE compared to other separation methods is the quality of protein resolution [
52] as shown by the capability of resolving many post-translationally modified proteins that may appear as isoforms. Identity of each protein spot was determined by mass spectrometry, which is the method of choice for accurate probability based protein identification. Moreover, it is unlikely that the results are flawed by unacceptable analytical errors; densitometric analyses combined with silver staining of proteins are highly quantitative and a median coefficient of variation of approximately 8 % has been reported using similar parameters as used in our procedure (i.e., fluorescent staining, PDQuest software) [
53].
Conclusions
In conclusion, we have identified a number of proteins that are present differently in the plasma of farmers with MSD and their rural referents. Many of these proteins are known to be mediators or indicators of inflammation, supporting the hypothesis that farmers with MSD may be subject to a more systemic inflammation. The implication of these findings is worth considering. First, it is possible that the identified proteins may give clues to the biochemical changes occurring during the development and progression of MSD in farmers and so contribute to a deeper understanding of the pathogenetic mechanisms behind MSD and related symptoms/findings in other organ systems. Second, one or several or a combination of the identified proteins might possibly be used as a biomarker(s) of MSD in farmers. Much further investigation is therefore warranted, including comparisons of farmers with and without MSD and referents with and without MSD to elucidate how MSD protein picture relates to exposure. Third, if it turns out that a plasma biomarker(s) appears early during the development of MSD in farmers, this biomarker(s) might eventually be used to identify farmers who are at greater risk and to prevent progression of the disease process.
This study provides novel information about the biological mechanisms behind MSD in farmers and makes it possible to explain the link between health outcomes and the work environment. We identify biomarkers of systemic inflammation that contribute to better understanding of the pathophysiological processes involved in MSD. Although farmers are a relatively small occupational group in Sweden today, the identification of the causes of work-related MSD in this group may be a valuable tool for understanding of similar phenomenon in other groups. The results of this study thus may contribute to a better understanding of how problems in the musculoskeletal system generally arise.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: AT, SH, CT and BG. Data collection of the questionnaires and clinical examinations: AT and SH. Performed the experiments: AC and BG. Analyzed the data: AC, CT and BG. All authors have contributed to write the manuscript, read and approved the final manuscript.